UnannouncedVCInvestor

Petrichor Scion Therapeutics

Startup rounds since 2015 with a Petrichor Scion Therapeutics investor on the board, and the firm's own fund filings.

Raises
20
since 2015
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name

Rounds

  1. Health Outlook Corp$1.4MFiled before 202520 Aug 2024 · New York, NY
  2. Health Outlook Corp$2.85MFiled before 202516 Jan 2024 · New York, NY
  3. Health Outlook Corp$4MFiled before 202528 Jul 2023 · New York, NY
  4. Palvella Therapeutics, Inc.$9.7MFiled before 202530 Dec 2022 · Wayne, PA
  5. RayzeBio, Inc.$168MFiled before 202522 Sep 2022 · San Diego, CA
  6. Health Outlook Corp$5.57MFiled before 202510 Jun 2022 · New York, NY
  7. Ceptur Therapeutics, Inc.$21.5MFiled before 20259 Mar 2022 · Hillsborough, NJ
  8. RayzeBio, Inc.$109MFiled before 202510 Jun 2021 · San Diego, CA
  9. RayzeBio, Inc.$105MFiled before 20251 Dec 2020 · San Diego, CA
  10. RayzeBio, Inc.$15MFiled before 20259 Nov 2020 · San Diego, CA
  11. Persivia Inc.$1.87MFiled before 20255 Aug 2019 · Marlborough, MA
  12. Persivia Inc.$3.12MFiled before 20255 Aug 2019 · Marlborough, MA
  13. Akero Therapeutics, Inc.$45.5MFiled before 202518 Dec 2018 · South San Francisco, CA
  14. Stoke Therapeutics, Inc.$90MFiled before 20252 Nov 2018 · Bedford, MA
  15. Corvidia Therapeutics, Inc.$60MFiled before 20251 May 2018 · Waltham, MA
  16. Syntimmune, Inc.$18MFiled before 202528 Jun 2017 · New York, NY
  17. Cure Forward Corp.$4.5MFiled before 202518 May 2017 · Boston, MA
  18. Cure Forward Corp.$4.33MFiled before 202529 Sep 2016 · Cambridge, MA
  19. Cure Forward Corp.$4MFiled before 202522 Jun 2015 · Cambridge, MA
  20. Cure Forward Corp.$3.5MFiled before 202522 Jun 2015 · Cambridge, MA

By year

YearRaisesUnannounced
20242
20231
20224
20211
20202
20192
20183
20172
20161
20152

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
Petrichor Scion Therapeutics LLC15 Mar 2023Open-ended$172M

Listed because a Petrichor Scion Therapeutics fund's filing names a director of each company. A name match is not a verified identity.